Ayurcin Biogenics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
- Revenue Growth 281.24%
- Profit Growth 246.32%
- Ebitda 300.68%
- Net Worth 42.27%
- Total Assets 3.12%
About Ayurcin Biogenics
Ayurcin Biogenics Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 10 January 2017 (Eight years and one month 15 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.50 M.
Abhijeet Panshikar and Ameya Panshikar serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100PN2017PTC167881
- Company No.
167881
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Ayurcin Biogenics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ameya Panshikar  | Director | 18-Jun-2019 | Current |
| Abhijeet Panshikar | Director | 10-Jan-2017 | Current |
Financial Performance of Ayurcin Biogenics.
Ayurcin Biogenics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 281.24% increase. The company also saw a substantial improvement in profitability, with a 246.32% increase in profit. The company's net worth Soared by an impressive increase of 42.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayurcin Biogenics?
Unlock access to Ayurcin Biogenics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ayurcin LimitedAbhijeet Panshikar and Ameya Panshikar are mutual person
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2017 | State Bank Of India | ₹0.50 M | Open |
How Many Employees Work at Ayurcin Biogenics?
Unlock and access historical data on people associated with Ayurcin Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayurcin Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayurcin Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
